Nu Skin Enterprises announced second quarter 2025 revenue of $386.1 million, which was at the high end of its guidance range of $355 million to $390 million. The company's diluted earnings per share (EPS) for the quarter was $0.43, exceeding its guidance of $0.20 to $0.30.
The Rhyz Manufacturing segment demonstrated strong performance, achieving 17% year-over-year revenue growth. Additionally, the Latin America segment showed encouraging growth, contributing positively to the overall results.
Gross margin for Q2 2025 was 68.8%, representing a 106 basis point expansion from the first quarter of 2025. This improvement in profitability, coupled with strong segment performance, highlights the impact of the company's operational optimization efforts.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.